4Hermansen K, Fontaine P, Kukolja KK, et al. Insulin analogues ( insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia, 2004,47 : 622-629.
5Heise T, Nosek L, Ronn BB,et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes, 2004,53 : 1614-1620.
6Oiknine R,Bembaum M, Mooradian AD. A critical appraisal of the role of insulin analogues in the management of diabetes mellltus. Drugs, 2005,65 : 325-340.
7Plank J, Siebenhofer A, Berghold A, et al. Systematic review and metaanalysis of short-acting insulin analogues in patients with diabetes mellims. Arch Intern Med, 2005,165:1337-1344.
8Kendall DM. Review: short-acting insulin analogues reduce glycosylated hemoglobin more than regular human insulin but only in adults with type 1 diabetes. ACP J Club,2005,142:62-63.
9Raskin PR, Hollander PA,Lewin A,et al.Basal insulin or premix analogue therapy in type 2 diabetes patients. Eur J Intem Med,2007,18:56-62.
10Czock D, Aisenpreis U, Rasche FM, et al. Pharmacokinetics and pharmacodynamies of lispro-insulin in hemodialysis patients with diabetes mellitus. Int J Clin Pharmacol Ther, 2003,41:492-497.
